Gut Microbiota‐Dependent Trimethylamine N‐oxide and Cardiovascular Outcomes in Patients With Prior Myocardial Infarction: A Nested Case Control Study From the PEGASUS‐TIMI 54 Trial

BACKGROUND: Trimethylamine N‐oxide (TMAO) may have prothrombotic properties. We examined the association of TMAO quartiles with major adverse cardiovascular events (MACE) and the effect of TMAO on the efficacy of ticagrelor. METHODS AND RESULTS: PEGASUS‐TIMI 54 (Prevention of Cardiovascular Events i...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Am Heart Assoc
Autors principals: Gencer, Baris, Li, Xinmin S., Gurmu, Yared, Bonaca, Marc P., Morrow, David A., Cohen, Marc, Bhatt, Deepak L., Steg, P. Gabriel, Storey, Robert F., Johanson, Per, Wang, Zeneng, Hazen, Stanley L., Sabatine, Marc S.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2020
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7660879/
https://ncbi.nlm.nih.gov/pubmed/32366163
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.119.015331
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars